Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of “Hold” by Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have received a consensus rating of “Hold” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $22.50.

A number of analysts have weighed in on MD shares. Deutsche Bank Aktiengesellschaft set a $19.00 target price on shares of Pediatrix Medical Group in a research report on Friday, February 20th. Jefferies Financial Group reiterated a “buy” rating and set a $27.00 price target on shares of Pediatrix Medical Group in a report on Monday, April 20th. UBS Group lifted their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. Finally, Truist Financial boosted their target price on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a report on Monday, April 13th.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD opened at $21.31 on Friday. The company’s 50 day simple moving average is $21.79 and its 200 day simple moving average is $21.73. The stock has a market capitalization of $1.75 billion, a price-to-earnings ratio of 10.34 and a beta of 0.70. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33. Pediatrix Medical Group has a 1 year low of $11.84 and a 1 year high of $24.99.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The business had revenue of $476.20 million for the quarter, compared to analysts’ expectations of $465.83 million. During the same period last year, the firm posted $0.33 earnings per share. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. As a group, research analysts predict that Pediatrix Medical Group will post 2.08 EPS for the current fiscal year.

Insider Transactions at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Pediatrix Medical Group

Several hedge funds and other institutional investors have recently bought and sold shares of MD. Wasatch Advisors LP bought a new stake in Pediatrix Medical Group in the first quarter valued at $43,861,000. Victory Capital Management Inc. increased its position in shares of Pediatrix Medical Group by 30.7% during the third quarter. Victory Capital Management Inc. now owns 4,126,207 shares of the company’s stock worth $69,114,000 after acquiring an additional 968,553 shares in the last quarter. American Century Companies Inc. increased its position in shares of Pediatrix Medical Group by 38.9% during the third quarter. American Century Companies Inc. now owns 2,682,976 shares of the company’s stock worth $44,940,000 after acquiring an additional 751,109 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new stake in shares of Pediatrix Medical Group during the fourth quarter worth about $13,613,000. Finally, Rockefeller Capital Management L.P. increased its position in shares of Pediatrix Medical Group by 814.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 594,351 shares of the company’s stock worth $12,713,000 after acquiring an additional 529,367 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.